FUSION PROTEINS THAT FACILITATE CANCER CELL DESTRUCTION

• 收藏
• 分享

专利权人:

发明人:

Mark L. Tykocinski

申请号：

US15830923

公开号：

US20180148512A1

申请日:

2017.12.04

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Provided is a fusion protein comprising a polypeptide component that blocks binding of CD47 to SIRP alpha and a polypeptide that binds to and triggers a TRAIL receptor or Fas. Also provided is a method of treating cancer in a patient comprising administering the fusion protein of the invention to a patient in need of such treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/